Collectively, our data show that ZNF217 is a potent oncogene that can impact ovarian cancer progression and metastasis by impacting multiple steps involved in this process and can also enable the tumor cells resist chemotherapeutics. The gene discussed is ZNF217; the disease is ovarian carcinoma.